DK0813869T3 - Anvendelse af strontiumsalte ved behandling af arthritis - Google Patents

Anvendelse af strontiumsalte ved behandling af arthritis

Info

Publication number
DK0813869T3
DK0813869T3 DK97401362T DK97401362T DK0813869T3 DK 0813869 T3 DK0813869 T3 DK 0813869T3 DK 97401362 T DK97401362 T DK 97401362T DK 97401362 T DK97401362 T DK 97401362T DK 0813869 T3 DK0813869 T3 DK 0813869T3
Authority
DK
Denmark
Prior art keywords
treatment
arthritis
strontium salts
strontium
salts
Prior art date
Application number
DK97401362T
Other languages
English (en)
Inventor
Yannis Tsouderos
Pascale Deloffre
Michel Wierzbicki
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK0813869T3 publication Critical patent/DK0813869T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DK97401362T 1996-06-17 1997-06-16 Anvendelse af strontiumsalte ved behandling af arthritis DK0813869T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9607475A FR2749759B1 (fr) 1996-06-17 1996-06-17 Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose

Publications (1)

Publication Number Publication Date
DK0813869T3 true DK0813869T3 (da) 2003-06-02

Family

ID=9493102

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97401362T DK0813869T3 (da) 1996-06-17 1997-06-16 Anvendelse af strontiumsalte ved behandling af arthritis

Country Status (16)

Country Link
US (1) US5856356A (da)
EP (1) EP0813869B1 (da)
JP (1) JP3935557B2 (da)
CN (1) CN1136856C (da)
AT (1) ATE233558T1 (da)
AU (1) AU711950B2 (da)
BR (1) BR9703603A (da)
CA (1) CA2206837C (da)
DE (1) DE69719408T2 (da)
DK (1) DK0813869T3 (da)
ES (1) ES2193337T3 (da)
FR (1) FR2749759B1 (da)
HU (1) HU227935B1 (da)
NO (1) NO315840B1 (da)
NZ (1) NZ328106A (da)
ZA (1) ZA975323B (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
NO20014746D0 (no) * 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844795B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
FR2846558B1 (fr) * 2002-11-05 2006-07-14 Servier Lab Utilisation du sel distrontique de l'acide 2-n,n-di(carboxymethyl)amino-3-cyano-4-carboxymethyl- thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales
EP1605955B1 (en) * 2003-03-27 2015-08-19 SantoSolve AS Anti-inflammatory composition based on strontium compounds
DK1622630T3 (da) * 2003-05-07 2012-12-17 Osteologix As P009368epdk1
ATE342722T1 (de) * 2003-05-07 2006-11-15 Osteologix As Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
WO2004098617A2 (en) * 2003-05-07 2004-11-18 Osteologix A/S Controlled release composition containing a strontium salt
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
PL1732575T3 (pl) * 2004-02-26 2011-05-31 Osteologix As Związki zawierające stron do stosowania w zapobieganiu lub leczeniu stanów nekrotycznych kości
CN101010087B (zh) * 2004-05-06 2012-06-27 奥斯泰奥洛吉斯公司 用于制备金属有机盐的高收率和快速的合成方法
AU2005254154A1 (en) * 2004-06-17 2005-12-29 Osteologix A/S Improving pain treatment with strontium combinations
JP2008502609A (ja) * 2004-06-17 2008-01-31 オステオロジックス エイ／エス リウマチおよび関節性疾患の治療改善方法
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US8658206B2 (en) * 2004-06-25 2014-02-25 Mokwalo SA Compositions comprising strontium and vitamin D and uses thereof
CN101018586B (zh) * 2004-06-25 2014-08-27 莫克瓦洛Spf有限公司 含锶和维生素d的组合物及其用途
FR2875807B1 (fr) 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EP1799196B1 (en) * 2004-10-08 2016-06-22 Forward Pharma A/S Controlled release pharmaceutical compositions comprising a fumaric acid ester
US20080004344A1 (en) * 2004-11-10 2008-01-03 Aditech Pharma Ab Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use
EP1855654A1 (en) * 2005-02-28 2007-11-21 Osteologix A/S Tablets comprising a high load of strontium
FR2899895B1 (fr) * 2006-04-12 2010-09-17 Servier Lab Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2651827C (en) * 2006-05-26 2013-11-26 Baxter International Inc. Injectable fibrin composition for bone augmentation
GB0612028D0 (en) * 2006-06-16 2006-07-26 Imp Innovations Ltd Bioactive glass
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
CN101204375B (zh) * 2006-12-19 2010-09-29 北京德众万全药物技术开发有限公司 一种雷奈酸锶干混悬剂
CN103785058B (zh) * 2007-04-23 2016-12-07 巴克斯特国际公司 包含锶化合物的纤维蛋白组合物
GB0713094D0 (en) * 2007-07-05 2007-08-15 Imp Innovations Ltd Glass polycarboxylate cements
GB0724556D0 (en) * 2007-12-17 2008-01-30 Queen Mary & Westfield College LAtency associated protein construct with aggrecanase sensitive cleavage site
EP2259803B2 (en) 2008-02-29 2019-03-13 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
WO2009144455A2 (en) * 2008-05-27 2009-12-03 Imperial Innovations Limited Process for producing porous scaffolds from sinterable glass
GB0809592D0 (en) * 2008-05-27 2008-07-02 Imp Innovations Ltd Biomaterials
UA125896C2 (uk) 2009-01-09 2022-07-06 Фвп Іп Апс Фармацевтичний склад, що містить в матриці, яка піддається ерозії, один або більше ефірів фумарової кислоти
GB0911365D0 (en) 2009-06-30 2009-08-12 Bioceramic Therapeutics Ltd Multicomponent glasses for use as coatings and in personal care products
FR2953139B1 (fr) 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
WO2011151386A1 (en) 2010-06-01 2011-12-08 Baxter International Inc. Process for making dry and stable hemostatic compositions
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
AU2012318258B2 (en) 2011-10-11 2015-07-09 Baxter Healthcare S.A. Hemostatic compositions
EP4137165A1 (en) 2011-10-11 2023-02-22 Baxter International Inc. Hemostatic compositions
WO2013060770A1 (en) 2011-10-27 2013-05-02 Baxter International Inc. Hemostatic compositions
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
RU2636240C2 (ru) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
CN105358071B (zh) 2013-06-21 2018-07-31 弗罗桑医疗设备公司 真空膨胀的干组合物和用于保留该干组合物的注射器
WO2015086028A1 (en) 2013-12-11 2015-06-18 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US11046818B2 (en) 2014-10-13 2021-06-29 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
CN107206165B (zh) 2014-12-24 2020-10-23 弗罗桑医疗设备公司 用于保持并混合第一和第二物质的注射器
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
US10463636B2 (en) 2016-09-30 2019-11-05 Deanna J. Nelson Pharmaceutical quality strontium L-lactate
EP3790600B1 (en) 2018-05-09 2023-12-27 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152431A (en) * 1977-09-22 1979-05-01 William H. Rorer, Inc. Compositions and method of use
FR2633619B1 (fr) * 1988-06-29 1991-02-08 Adir Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.

Also Published As

Publication number Publication date
HU227935B1 (en) 2012-06-28
ZA975323B (en) 1998-01-14
HUP9701059A2 (hu) 1998-03-02
NO315840B1 (no) 2003-11-03
DE69719408D1 (de) 2003-04-10
US5856356A (en) 1999-01-05
ATE233558T1 (de) 2003-03-15
FR2749759B1 (fr) 1999-11-26
NZ328106A (en) 2001-04-27
HU9701059D0 (en) 1997-08-28
EP0813869A1 (fr) 1997-12-29
CN1136856C (zh) 2004-02-04
CA2206837A1 (fr) 1997-12-17
JP3935557B2 (ja) 2007-06-27
AU2490297A (en) 1998-01-08
DE69719408T2 (de) 2003-12-24
EP0813869B1 (fr) 2003-03-05
JPH1059852A (ja) 1998-03-03
FR2749759A1 (fr) 1997-12-19
CA2206837C (fr) 2002-12-03
HUP9701059A3 (en) 1998-05-28
AU711950B2 (en) 1999-10-28
CN1179944A (zh) 1998-04-29
NO972764D0 (no) 1997-06-16
ES2193337T3 (es) 2003-11-01
BR9703603A (pt) 1998-09-01
NO972764L (no) 1997-12-18

Similar Documents

Publication Publication Date Title
DK0813869T3 (da) Anvendelse af strontiumsalte ved behandling af arthritis
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
ES2052871T3 (es) Preparacion de bis (3,5-di-t-butil-4-hidroxifeniltio)metano.
AR052907A1 (es) Compuesto 14,15-deshidro-16-oxoparahercuamida y compuestos 2- desoxo de parahercuamida y marcfortina
BR9101322A (pt) Processo de incineracao de residuos e composicoes de incineracao
DE69320362D1 (de) Nicht-wässrige emulgierte oberflächenbehandlungszusammensetzung
FI940932L (fi) Koostumuksia ja menetelmiä haavojen hoitamiseksi
TR200202323T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavß6 antagonistleriyle tedavisi
DE69713643D1 (de) Na, K und Li Salze von Siloxy-Verbindungen
FI971750A0 (fi) Koostumuksia multippeliskleroosia varten ja sen hoito
DE69916629D1 (de) Taurolidin und/oder taurultam zur behandlung von infektiösen ulcera oder gastritis
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
FI951163A7 (fi) Jätteen käsittely
DK0680505T3 (da) Behandling af spildolie
DE69119259D1 (de) Regeln von Öfen zur Wärmebehandlung
DK221690D0 (da) Anvendelse af dimethylpolysiloxaner til behandling af sygdomme i det gastrointestinale omraade
NO885491D0 (no) Fremgangsmaate for reduksjon av avleiringer i anlegg for inndampning av sulfittavlut.
DE69301904D1 (de) Zusammensetzung zur behandlung von keratinfasern
KR950700746A (ko) 양성 전립선 비대를 치료하는 조성물 및 방법(Compositions and Methods For Treating Benign Prostatic Hypertrophy)
DE59305800D1 (de) Werkzeug zur behandlung von oberflächen von bauteilen
FR2784677B1 (fr) Procede de traitement et d'utilisation d'un machefer resultant de l'incineration d'ordures menageres
DE69400223D1 (de) Verwendung von Textilbehandlungszusammensetzungen
DK435089A (da) Anvendelse af zofenopril til behandling af rheumatoid arthritis
ITMI913098A0 (it) Forno multiplo per la combustione di fanghi e rifiuti
SE9403861D0 (sv) Novel medicinal use